Karl Chalabala
Stock Analyst at UBS
(0.46)
# 3,867
Out of 4,814 analysts
8
Total ratings
25%
Success rate
-10.82%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Karl Chalabala
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
FOLD Amicus Therapeutics | Maintains: Buy | $19 → $21 | $6.83 | +207.69% | 5 | Nov 7, 2024 | |
SCCO Southern Copper | Maintains: Sell | $47 → $50 | $86.27 | -42.56% | 1 | Feb 23, 2023 | |
CRK Comstock Resources | Maintains: Buy | $14 → $12 | $19.76 | -39.27% | 1 | Aug 14, 2017 | |
GPOR Gulfport Energy | Maintains: Buy | $21 → $18 | $173.94 | -89.65% | 1 | Aug 14, 2017 |
Amicus Therapeutics
Nov 7, 2024
Maintains: Buy
Price Target: $19 → $21
Current: $6.83
Upside: +207.69%
Southern Copper
Feb 23, 2023
Maintains: Sell
Price Target: $47 → $50
Current: $86.27
Upside: -42.56%
Comstock Resources
Aug 14, 2017
Maintains: Buy
Price Target: $14 → $12
Current: $19.76
Upside: -39.27%
Gulfport Energy
Aug 14, 2017
Maintains: Buy
Price Target: $21 → $18
Current: $173.94
Upside: -89.65%